Reported Earnings • Mar 10
First half 2026 earnings released: EPS: UK£0.019 (vs UK£0.003 in 1H 2025) First half 2026 results: EPS: UK£0.019 (up from UK£0.003 in 1H 2025). Revenue: UK£153.9m (up 188% from 1H 2025). Net income: UK£2.60m (up UK£2.20m from 1H 2025). Profit margin: 1.7% (up from 0.7% in 1H 2025). Revenue is expected to decline by 35% p.a. on average during the next 2 years, while revenues in the Insurance industry in the United Kingdom are expected to grow by 3.6%. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Declared Dividend • Mar 08
First half dividend of UK£0.018 announced Dividend of UK£0.018 is the same as last year. Ex-date: 12th March 2026 Payment date: 23rd April 2026 Dividend yield will be 8.6%, which is higher than the industry average of 5.0%. Sustainability & Growth Dividend is not covered by earnings (155% earnings payout ratio) nor is it covered by cash flows (101% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 72% to bring the payout ratio under control. However, EPS has declined by 3.0% over the last 5 years so the company would need to reverse this trend. New Risk • Mar 06
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 155% Cash payout ratio: 101% Dividend yield: 8.6% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 155% Cash payout ratio: 101% Earnings have declined by 8.2% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (UK£70.3m market cap, or US$93.6m). Annuncio • Mar 06
Hansard Global plc Declares Interim Dividend, Payable on 23 April 2026 Hansard Global plc resolved to pay an interim dividend of 1.8 pence per share, consistent with previous years. This amounts to £2.5 million and will be paid on 23 April 2026 to shareholders on the register at 13 March 2026. Declared Dividend • Sep 28
Final dividend of UK£0.026 announced Dividend of UK£0.026 is the same as last year. Ex-date: 2nd October 2025 Payment date: 13th November 2025 Dividend yield will be 9.1%, which is higher than the industry average of 5.0%. Sustainability & Growth Dividend is not covered by earnings (340% earnings payout ratio). However, it is well covered by cash flows (47% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 278% to bring the payout ratio under control. However, EPS has declined by 17% over the last 5 years so the company would need to reverse this trend. New Risk • Sep 25
New major risk - Revenue and earnings growth Earnings have declined by 6.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.5% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (0% payout ratio). Market cap is less than US$100m (UK£67.1m market cap, or US$89.5m). Reported Earnings • Sep 25
Full year 2025 earnings released: EPS: UK£0.013 (vs UK£0.038 in FY 2024) Full year 2025 results: EPS: UK£0.013 (down from UK£0.038 in FY 2024). Revenue: UK£80.6m (down 52% from FY 2024). Net income: UK£1.80m (down 65% from FY 2024). Profit margin: 2.2% (down from 3.1% in FY 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. New Risk • Sep 22
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Dividend is not well covered by earnings (383% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (UK£68.5m market cap, or US$92.3m). Annuncio • Jul 25
Hansard Global plc Announces Board and Remuneration Committee Changes, Effective 5 November 2025 Hansard Global plc announced the resignation of Elizabeth Noel Harwerth, OBE, Non-executive Director, with effect from 5 November 2025. Mrs. Harwerth has taken the decision to step down from the Board of the Company to focus on her other commitments and will not be offering herself for re-election at the Company's 2025 Annual General Meeting. Mrs. Harwerth will step down with immediate effect from her roles as Senior Independent Director and Chair of the Remuneration Committee. Lynzi Harrison will succeed her in both positions. The Board's search for a new Independent Non-executive Director has commenced and an update will be provided in due course. New Risk • Apr 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (UK£60.2m market cap, or US$78.8m). Annuncio • Mar 17
Hansard Global plc Announces Demise of Leonard Polonsky, Founder Hansard Global plc announced the death (at the age of 97) of its founder, controlling shareholder (under the Leonard Polonsky Revocable Trust) and President, Dr Leonard Polonsky CBE. Dr Polonsky died on Friday 14th March at his home in New York surrounded by loved ones. Dr Polonsky began working in financial services in New York in 1955, gaining experience of working in Rome, Frankfurt and Zurich, before establishing Liberty Life Assurance Company Limited in London in 1970. Hansard Global plc, its successor, has been listed on the London Stock Exchange since 2006. A keen philanthropist, Dr Polonsky's legacy will live on through the Polonsky Foundation, a UK-registered charity which supports higher education, cultural heritage and the arts in the UK, the USA, Israel and Europe. Dr Polonsky's commitment to giving back was recognised in 2013, when he was named a Commander of the British Empire for charitable services by HM Queen Elizabeth II. Known for his charm and creativity, his tireless enthusiasm for Hansard's business and industry, and his deep interest in Hansard's people, Dr Polonsky lived a remarkably full life, earning the respect and admiration of business colleagues, academics and philanthropic beneficiaries across the world. The Leonard Polonsky Revocable Trust continues to hold Dr Polonsky's shares in the company and is now the controlling shareholder. This Trust was established in 2018 to provide for the orderly control of the shares in the event of Dr Polonsky's death or incapacity. Policyholders, advisers, employees and all other key stakeholders of the business are assured that, despite this sad news, Hansard will continue to operate as usual. The management and staff of Hansard share their deepest condolences with Dr Polonsky's family and friends at this sad time. Declared Dividend • Mar 09
Final dividend of UK£0.018 announced Dividend of UK£0.018 is the same as last year. Ex-date: 13th March 2025 Payment date: 24th April 2025 Dividend yield will be 9.0%, which is higher than the industry average of 5.0%. Sustainability & Growth Dividend is not covered by earnings (118% earnings payout ratio) nor is it covered by cash flows (264% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 31% to bring the payout ratio under control, which is more than the 2.7% EPS growth achieved over the last 5 years. Annuncio • Mar 06
Hansard Global plc Declares Interim Dividend, Payable on April 24, 2025 Hansard Global plc declared an interim dividend of 1.8p per share, consistent with previous years. This will be paid on 24 April 2025 with an ex-dividend date of 13 March 2025. Annuncio • Dec 17
Hansard Global plc Announces Board and Committee Changes, Effective 31 December 2024 Hansard Global plc announced that Noel Harwerth, OBE will succeed Jose Ribeiro as Chair of the Remuneration Committee and Senior Independent Director (SID) with effect from 31 December 2024. Noel joined the Board in September 2024 as an Independent Non-Executive Director and, as previously reported, has extensive experience which includes chairing board committees and acting as SID, making Noel a natural successor for both roles. Annuncio • Nov 28
Hansard Global plc Announces Board and Committee Changes Hansard Global plc announced that Jose Ribeiro has advised the Board that he will step down as Independent Non-Executive Director, Senior Independent Director, and Chair of the Remuneration Committee of the Company with effect from 31 December 2024. Jose's decision follows his recent appointment at Starr Insurance as President, Asia Pacific (APAC) and Latin America (LATAM) which he will take up on 1 January 2025. Jose has advised the Board that due to his new executive role he will be unable to dedicate sufficient time to contribute to the Company appropriately. Following a process led by the Nominations Committee, and supported by an independent executive search firm, the Company announced the appointment of Lynzi Harrison as an Independent Non-Executive Director of the Company with effect from 11 December 2024. Lynzi has over 25 years of relevant industry experience, spending 19 years in a variety of roles with Old Mutual. Lynzi currently serves on the boards of Omnilife Ltd, Irwin Mitchell Asset Management Limited, Personal Touch Financial Services Ltd. (part of the PRIMIS Group) and Holloway Friendly Society, and is a non-executive member of the With Profit Committee of Utmost L&P. The Nominations Committee will, at its December meetings, consider and determine who will assume the roles of Senior Independent Director and Chair of the Remuneration Committee from 1 January 2025. Annuncio • Nov 14
Hansard Global plc Approves Final Dividend Hansard Global plc at its Annual General Meeting held on 13 November 2024, approved a final dividend of 2.65 pence per share. Declared Dividend • Sep 29
Final dividend of UK£0.026 announced Dividend of UK£0.026 is the same as last year. Ex-date: 3rd October 2024 Payment date: 14th November 2024 Dividend yield will be 8.6%, which is higher than the industry average of 5.0%. Sustainability & Growth Dividend is not covered by earnings (118% earnings payout ratio) nor is it covered by cash flows (264% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 31% to bring the payout ratio under control, which is more than the 2.7% EPS growth achieved over the last 5 years. Reported Earnings • Sep 27
Full year 2024 earnings released: EPS: UK£0.038 (vs UK£0.041 in FY 2023) Full year 2024 results: EPS: UK£0.038 (down from UK£0.041 in FY 2023). Revenue: UK£169.1m (up 88% from FY 2023). Net income: UK£5.20m (down 8.8% from FY 2023). Profit margin: 3.1% (down from 6.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 34% p.a. on average during the next 2 years, while revenues in the Insurance industry in the United Kingdom are expected to grow by 9.5%. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Annuncio • Sep 24
Hansard Global plc Announces Appointment of Noel Harwerth, OBE as an Independent Non-Executive Director Hansard Global plc announced the appointment of Mrs. Noel Harwerth, OBE as an Independent Non-Executive Director of the Company with effect from 23 September 2024. Noel is a highly experienced non-executive director who has sat on a number of boards in a variety of different sectors, including mining and finance industry companies and will bring with her a wealth of knowledge. Noel currently serves on the boards of OSB Group Plc (as Senior Independent Director) and CAB Payments Holdings plc. Prior roles include Chair of the UK Export Finance Agency (until February 2024) and member of the Boards of the UK Department of Business and Trade, Scotia Bank Europe, Standard Life, London Metals Exchange, and Bank of England RTGS/CHAPS Board. Noel served as Chairman of Sumitomo Mitsui Bank (Europe, Middle East and Africa) from 2004 to June 2015. From 1998 to 2004, Noel was Chief Operating Officer of Citibank International PLC in London. She was responsible for infrastructure and governance of Europe's first truly pan European bank with branches in 18 countries. Noel was educated at the University of Texas in Austin and holds a Juris Doctor Degree from the University of Texas Law School. She has both US and British citizenship. Current Directorships: OSB Group Plc, CAB Payments Holdings plc. New Risk • Sep 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 91% Paying a dividend despite having no free cash flows. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Market cap is less than US$100m (UK£67.4m market cap, or US$89.7m). Major Estimate Revision • Mar 14
Consensus EPS estimates increase by 21% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from UK£0.036 to UK£0.044. Revenue forecast unchanged at UK£93.0m. Net income forecast to shrink 15% next year vs 3.4% growth forecast for Insurance industry in the United Kingdom . Consensus price target of UK£0.65 unchanged from last update. Share price was steady at UK£0.51 over the past week. Reported Earnings • Mar 11
First half 2024 earnings released: EPS: UK£0.029 (vs UK£0.022 in 1H 2023) First half 2024 results: EPS: UK£0.029 (up from UK£0.022 in 1H 2023). Revenue: UK£68.2m (up 48% from 1H 2023). Net income: UK£4.00m (up 33% from 1H 2023). Profit margin: 5.9% (down from 6.5% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 6.3% p.a. on average during the next 2 years, while revenues in the Insurance industry in the United Kingdom are expected to grow by 25%. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Declared Dividend • Mar 10
First half dividend of UK£0.018 announced Dividend of UK£0.018 is the same as last year. Ex-date: 14th March 2024 Payment date: 25th April 2024 Dividend yield will be 8.8%, which is higher than the industry average of 5.0%. Sustainability & Growth Dividend is not adequately covered by earnings (92% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 2.1% to bring the payout ratio under control. However, EPS is expected to decline by 14% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio. Annuncio • Mar 09
Hansard Global plc Declares Interim Dividend, Payable on 25 April 2024 Taking into account the current financial position and future outlook, the Board of Hansard Global plc has resolved to maintain its interim dividend at 1.8 pence per share (H1 2023: 1.8 pence per share). This will be paid on 25 April 2024 with an ex-dividend date of 14 March 2024. Annuncio • Feb 15
Hansard Global plc Announces Resignation of Christine Theodorovics as Independent Non-Executive Director, effective 29 February 2024 Hansard Global plc announced the resignation of Dr. Christine Theodorovics, Independent Non-executive Director, with effect from 29 February 2024. Dr. Theodorovics was appointed Chief Executive Officer of Baloise Luxembourg last year and has taken the decision to step down from the Board to focus on this commitment. The Board's search for a new Independent Non-executive Director has commenced. Reported Earnings • Oct 02
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: UK£0.041 (up from UK£0.026 in FY 2022). Net income: UK£5.70m (up 58% from FY 2022). Revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Oct 01
Hansard Global plc Proposes Final Dividend, Payable on 16 November 2023 The Board of Hansard Global plc has proposed a final dividend of 2.65 pence per share, the same level as last year. This dividend, if approved by the shareholders at the Annual General Meeting on 8 November 2023, represents a total dividend of 4.45 pence (2022: 4.45 pence) per share in respect of the financial year. Upon approval, the dividend will be paid on 16 November 2023 to shareholders on the register on 6 October 2023. The associated ex-dividend date is 5 October 2023. Annuncio • Sep 29
Hansard Global plc to Report Q2, 2024 Results on Mar 07, 2024 Hansard Global plc announced that they will report Q2, 2024 results on Mar 07, 2024 Major Estimate Revision • Sep 29
Consensus EPS estimates increase by 34% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from UK£0.027 to UK£0.036. Revenue forecast unchanged at UK£93.0m. Net income forecast to shrink 11% next year vs 132% growth forecast for Insurance industry in the United Kingdom . Consensus price target of UK£0.65 unchanged from last update. Share price rose 11% to UK£0.46 over the past week. New Risk • Sep 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 128% Paying a dividend despite having no free cash flows. Earnings are forecast to decline by an average of 15% per year for the foreseeable future. Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (-8.6% net profit margin). Market cap is less than US$100m (UK£57.1m market cap, or US$69.8m). New Risk • Sep 10
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 128% Paying a dividend despite having no free cash flows. Earnings are forecast to decline by an average of 15% per year for the foreseeable future. Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (-8.6% net profit margin). Market cap is less than US$100m (UK£56.2m market cap, or US$70.0m). Buying Opportunity • Jun 19
Now 20% undervalued Over the last 90 days, the stock is up 7.6%. The fair value is estimated to be UK£0.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 53% over the last 3 years. Earnings per share has declined by 2.7%. Buying Opportunity • May 10
Now 20% undervalued Over the last 90 days, the stock is up 17%. The fair value is estimated to be UK£0.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 53% over the last 3 years. Earnings per share has declined by 2.7%. Annuncio • May 05
Hansard Global plc Provides Sales Guidance for 2023 Hansard Global plc announced that the company expects sales of long-term savings products through Independent Financial Advisors to continue to be impacted by global economic headwinds. Looking forward however the company is confident that new product pipeline will lead to increased sales and long term growth in the business. Major Estimate Revision • Mar 16
Consensus EPS estimates increase by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from UK£0.024 to UK£0.027. Revenue forecast unchanged at UK£101.5m. Net income forecast to shrink 17% next year vs 124% growth forecast for Insurance industry in the United Kingdom . Consensus price target of UK£0.65 unchanged from last update. Share price was steady at UK£0.48 over the past week. Buying Opportunity • Mar 16
Now 21% undervalued Over the last 90 days, the stock is up 23%. The fair value is estimated to be UK£0.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 53% over the last 3 years. Earnings per share has declined by 2.7%. Reported Earnings • Mar 10
First half 2023 earnings released: EPS: UK£0.022 (vs UK£0.013 in 1H 2022) First half 2023 results: EPS: UK£0.022 (up from UK£0.013 in 1H 2022). Net income: UK£3.00m (up 67% from 1H 2022). Revenue is forecast to grow 108% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Major Estimate Revision • Jan 27
Consensus revenue estimates fall by 13% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from UK£116.8m to UK£101.5m. EPS estimate fell from UK£0.025 to UK£0.024 per share. Net income forecast to shrink 8.3% next year vs 13% growth forecast for Insurance industry in the United Kingdom . Consensus price target of UK£0.65 unchanged from last update. Share price fell 6.0% to UK£0.39 over the past week. Price Target Changed • Nov 16
Price target increased to UK£0.65 Up from UK£0.60, the current price target is provided by 1 analyst. New target price is 51% above last closing price of UK£0.43. Stock is down 10% over the past year. The company is forecast to post earnings per share of UK£0.025 for next year compared to UK£0.026 last year. Reported Earnings • Sep 23
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: UK£0.026 (down from UK£0.036 in FY 2021). Net income: UK£3.60m (down 27% from FY 2021). Revenue is forecast to grow 90% p.a. on average during the next 2 years, compared to a 29% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 5% per year and the company’s share price has also fallen by 5% per year. Price Target Changed • Apr 27
Price target increased to UK£0.65 Up from UK£0.60, the current price target is provided by 1 analyst. New target price is 36% above last closing price of UK£0.48. Stock is down 18% over the past year. The company is forecast to post earnings per share of UK£0.039 for next year compared to UK£0.036 last year. Board Change • Apr 27
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Group CEO & Executive Director Graham Sheward was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Mar 10
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from UK£0.05 to UK£0.04. Revenue forecast unchanged from UK£149.0m at last update. Net income forecast to grow 54% next year vs 5.1% decline forecast for Insurance industry in the United Kingdom. Consensus price target of UK£0.65 unchanged from last update. Share price fell 2.7% to UK£0.46 over the past week. Reported Earnings • Mar 05
First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First half 2022 results: EPS: UK£0.013 (down from UK£0.02 in 1H 2021). Revenue: UK£47.9m (down 61% from 1H 2021). Net income: UK£1.80m (down 36% from 1H 2021). Profit margin: 3.8% (up from 2.3% in 1H 2021). Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 10%, compared to a 83% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Major Estimate Revision • Jan 28
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from UK£179.7m to UK£149.0m. EPS estimate unchanged from UK£0.046 per share at last update. Insurance industry in the United Kingdom expected to see average net income decline 0.09% next year. Consensus price target of UK£0.65 unchanged from last update. Share price fell 2.4% to UK£0.48 over the past week. Board Change • Dec 06
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Group CEO & Executive Director Graham Sheward was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 24
Full year 2021 earnings released: EPS UK£0.036 (vs UK£0.033 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: UK£214.7m (up 318% from FY 2020). Net income: UK£4.90m (up 8.9% from FY 2020). Profit margin: 2.3% (down from 8.8% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Executive Departure • May 15
Group CEO & Director Gordon Marr has left the company On the 10th of May, Gordon Marr, was replaced as CEO by Graham Sheward after 8.4 years in the role. As of December 2020, Gordon personally held 680.49k shares (UK£304k worth at the time). A total of 2 executives have left over the last 12 months. Under Gordon's leadership, the company delivered a total shareholder return of 21%. Reported Earnings • Mar 07
First half 2021 earnings released: EPS UK£0.02 (vs UK£0.019 in 1H 2020) The company reported a solid first half result with improved earnings and revenues, although profit margins were weaker. First half 2021 results: Revenue: UK£124.1m (up 276% from 1H 2020). Net income: UK£2.80m (up 7.7% from 1H 2020). Profit margin: 2.3% (down from 7.9% in 1H 2020). Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 16% per year. Price Target Changed • Mar 06
Price target raised to UK£0.60 Up from UK£0.53, the current price target is provided by 1 analyst. The new target price is 27% above the current share price of UK£0.47. As of last close, the stock is up 17% over the past year. Is New 90 Day High Low • Mar 03
New 90-day high: UK£0.51 The company is up 31% from its price of UK£0.39 on 03 December 2020. The British market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 10.0% over the same period. Major Estimate Revision • Feb 02
Analysts update estimates The 2021 consensus earning per share (EPS) estimate was lowered from UK£0.041 to UK£0.033. No change was made to the revenue estimate which at the last update was UK£157.7m. Net income is expected to grow by 24% next year compared to 12% growth forecast for the Insurance industry in the United Kingdom. The consensus price target of UK£0.53 was unchanged from the last update. Share price is down by 7.8% to UK£0.44 over the past week. Is New 90 Day High Low • Jan 21
New 90-day high: UK£0.48 The company is up 55% from its price of UK£0.31 on 23 October 2020. The British market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 25% over the same period. Is New 90 Day High Low • Dec 29
New 90-day high: UK£0.44 The company is up 12% from its price of UK£0.39 on 30 September 2020. The British market is also up 12% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Insurance industry, which is up 22% over the same period. Is New 90 Day High Low • Dec 07
New 90-day high: UK£0.40 The company is up 15% from its price of UK£0.35 on 08 September 2020. The British market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 15% over the same period. Is New 90 Day High Low • Sep 26
New 90-day high: UK£0.39 The company is up 20% from its price of UK£0.33 on 26 June 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is down 3.0% over the same period. 
